Gilliland Jeter Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,708
Closed -$1.52M 176
2025
Q2
$1.52M Sell
11,708
-1,000
-8% -$145K 0.49% 47
2025
Q1
$2.02M Sell
12,708
-15
-0.1% -$2.71K 0.72% 40
2024
Q4
$2.36M Sell
12,723
-100
-0.8% -$19.4K 0.8% 34
2024
Q3
$2.71M Sell
12,823
-2,685
-17% -$466K 0.87% 27
2024
Q2
$2.08M Buy
15,508
+125
+0.8% +$23.7K 0.7% 38
2024
Q1
$3.3M Sell
15,383
-1,180
-7% -$231K 1.15% 20
2023
Q4
$3.37M Buy
+16,563
New +$2.68M 1.39% 15

Other funds holding INSP

Gilliland Jeter Wealth Management's INSP Position: Q3 2025 in Review

Gilliland Jeter Wealth Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 11,708 shares — an estimated $1.52M sold.

Gilliland Jeter Wealth Management first reported a position in INSP in Q4 2023 and held it in 7 quarters. The position peaked at $3.37M in Q4 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Gilliland Jeter Wealth Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Gilliland Jeter Wealth Management sold 11,708 Inspire Medical Systems shares in Q3 2025, an estimated $1.52M.
  • Gilliland Jeter Wealth Management first reported a position in Inspire Medical Systems in Q4 2023 and held it in 7 quarters.
  • Gilliland Jeter Wealth Management's Inspire Medical Systems position peaked at $3.37M in Q4 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Gilliland Jeter Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.